The significance of partial volume effect on the estimation of hypoxic tumour volume with [18F]FMISO PET/CT

zu Verbundenen Objekten

Abstract: Background
The purpose of this study was to evaluate how a retrospective correction of the partial volume effect (PVE) in [18F]fluoromisonidazole (FMISO) PET imaging, affects the hypoxia discoverability within a gross tumour volume (GTV). This method is based on recovery coefficients (RC) and is tailored for low-contrast tracers such as FMISO. The first stage was the generation of the scanner’s RC curves, using spheres with diameters from 10 to 37 mm, and the same homogeneous activity concentration, positioned in lower activity concentration background. Six sphere-to-background contrast ratios were used, from 10.0:1, down to 2.0:1, in order to investigate the dependence of RC on both the volume and the contrast ratio. The second stage was to validate the recovery-coefficient correction method in a more complex environment of non-spherical lesions of different volumes and inhomogeneous activity concentration. Finally, we applied the correction method to a clinical dataset derived from a prospective imaging trial (DRKS00003830): forty nine head and neck squamous cell carcinoma (HNSCC) cases who had undergone FMISO PET/CT scanning for the quantification of tumour hypoxia before (W0), 2 weeks (W2) and 5 weeks (W5) after the beginning of radiotherapy. Here, PVE was found to cause an underestimation of the activity in small volumes with high FMISO signal.

Results
The application of the proposed correction method resulted in a statistically significant increase of both the hypoxic subvolume (171% at W0, 691% at W2 and 4.60 × 103% at W5 with p < 0.001) and the FMISO standardised uptake value (SUV) (27% at W0, 21% at W2 and by 25% at W5 with p < 0.001) within the primary GTV.

Conclusions
The proposed PVE-correction method resulted in a statistically significant increase of the hypoxic fraction (HF) with p < 0.001 and demonstrated results in better agreement with published HF data for HNSCC. To summarise, the proposed RC-based correction method can be a useful tool for a retrospective compensation against PVE

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
EJNMMI Physics. - 11, 1 (2024) , 43, ISSN: 2197-7364

Ereignis
Veröffentlichung
(wo)
Freiburg
(wer)
Universität
(wann)
2024
Urheber

DOI
10.1186/s40658-024-00643-1
URN
urn:nbn:de:bsz:25-freidok-2488114
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
25.03.2025, 13:46 MEZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

Entstanden

  • 2024

Ähnliche Objekte (12)

The distribution of the proteins involved in inositol-1,4,5-trisphosphate-mediated calcium release in the hippocampus : = Die Verteilung von Proteinen der inositol-1,4,5-trisphosphat-vermittelten Kalzium-Freisetzung im Hippocampus

Hochschulschrift

The distribution of the proteins involved in inositol-1,4,5-trisphosphate-mediated calcium release in the hippocampus : = Die Verteilung von Proteinen der inositol-1,4,5-trisphosphat-vermittelten Kalzium-Freisetzung im Hippocampus

The hypoxic tumour microenvironment

The hypoxic tumour microenvironment

Moderate Dosisdeeskalation der definitiven Cisplatin-basierten Radiochemotherapie für HPV-positive Oropharynxkarzinompatienten : : Ergebnisse der NRG-HN002-Studie = Moderate dose de-escalation of cisplatin-based chemoradiation for HPV-associated oropharyngeal carcinoma : results of the NRG-HN002 trial

Moderate Dosisdeeskalation der definitiven Cisplatin-basierten Radiochemotherapie für HPV-positive Oropharynxkarzinompatienten : : Ergebnisse der NRG-HN002-Studie = Moderate dose de-escalation of cisplatin-based chemoradiation for HPV-associated oropharyngeal carcinoma : results of the NRG-HN002 trial

Wöchentliche versus dreiwöchentliche Cisplatingabe bei der postoperativen Radiochemotherapie von lokal fortgeschrittenen Kopf-Hals-Plattenepithelkarzinomen – Ergebnisse der JCOG1008-Studie : = Weekly versus three-weekly cisplatin for the postoperative chemoradiation of locally advanced head-and-neck squamous cell carcinoma: results of the JCOG1008 trial

Wöchentliche versus dreiwöchentliche Cisplatingabe bei der postoperativen Radiochemotherapie von lokal fortgeschrittenen Kopf-Hals-Plattenepithelkarzinomen – Ergebnisse der JCOG1008-Studie : = Weekly versus three-weekly cisplatin for the postoperative chemoradiation of locally advanced head-and-neck squamous cell carcinoma: results of the JCOG1008 trial

Bestrahlungsplan-Analysen bei Patientinnen mit bilateralen Mammakarzinomen : inzidentelle Dosisbelastungen und Toxizitäten im Vergleich verschiedener Bestrahlungsverfahren

Hochschulschrift

Bestrahlungsplan-Analysen bei Patientinnen mit bilateralen Mammakarzinomen : inzidentelle Dosisbelastungen und Toxizitäten im Vergleich verschiedener Bestrahlungsverfahren

Aggressive Deeskalation der Strahlentherapie bei HPV-assoziierten Oropharynxkarzinomen auf der Basis der Hypoxiedynamik

Aggressive Deeskalation der Strahlentherapie bei HPV-assoziierten Oropharynxkarzinomen auf der Basis der Hypoxiedynamik

Deeskalation der adjuvanten Radiotherapie nach transoraler Resektion HPV-positiver Oropharynxkarzinome: Ergebnisse der E3311-Studie : = De-escalation of adjuvant radiotherapy after transoral surgery of HPV-associated oropharyngeal cancer: results of the E3311 trial

Deeskalation der adjuvanten Radiotherapie nach transoraler Resektion HPV-positiver Oropharynxkarzinome: Ergebnisse der E3311-Studie : = De-escalation of adjuvant radiotherapy after transoral surgery of HPV-associated oropharyngeal cancer: results of the E3311 trial

ORATOR2-Studie – randomisierter Vergleich einer primären Operation oder primären Strahlentherapie bei HPV-positivem Oropharynxkarzinom im Kontext einer Therapiedeeskalation : = ORATOR2 trial: randomized comparison of primary surgery vs. primary radiotherapy for HPV-associated oropharyngeal cancer in the context of de-escalated therapy

ORATOR2-Studie – randomisierter Vergleich einer primären Operation oder primären Strahlentherapie bei HPV-positivem Oropharynxkarzinom im Kontext einer Therapiedeeskalation : = ORATOR2 trial: randomized comparison of primary surgery vs. primary radiotherapy for HPV-associated oropharyngeal cancer in the context of de-escalated therapy

The particle radiobiology of multipotent mesenchymal stromal cells: a key to mitigating radiation-induced tissue toxicities in cancer treatment and beyond?

The particle radiobiology of multipotent mesenchymal stromal cells: a key to mitigating radiation-induced tissue toxicities in cancer treatment and beyond?

De-Escalation Strategies of (Chemo)Radiation for Head-and-Neck Squamous Cell Cancers—HPV and Beyond

De-Escalation Strategies of (Chemo)Radiation for Head-and-Neck Squamous Cell Cancers—HPV and Beyond

Evolution of the hypoxic compartment on sequential oxygen partial pressure maps during radiochemotherapy in advanced head and neck cancer

Evolution of the hypoxic compartment on sequential oxygen partial pressure maps during radiochemotherapy in advanced head and neck cancer

Authors’ response to the letter to the editor by Busra Yilmaz and Ugur Selek regarding our study “The influence of antibiotic administration on the outcomes of head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiation”

Authors’ response to the letter to the editor by Busra Yilmaz and Ugur Selek regarding our study “The influence of antibiotic administration on the outcomes of head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiation”

Verbundene Objekte